UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Targeting the VEGF pathway in metastatic bladder cancer

Expert opinion on investigational drugs, 2015-07, Vol.24 (7), p.913-927

2015

Volltextzugriff (PDF)

Long-term Outcomes of Patients with Lymph Node Metastasis Treated with Radical Prostatectomy Without Adjuvant Androgen-deprivation Therapy

European urology, 2014-01, Vol.65 (1), p.20-25

2014

Volltextzugriff (PDF)

Animal models of spontaneous renal carcinoma: A possible rebirth?

Urologic oncology, 2020-04, Vol.38 (4), p.174-183

2020

Volltextzugriff (PDF)

Heading Towards a Possible Rebirth of the Induced Renal Cell Carcinoma Models?

Cancers, 2020-03, Vol.12 (3), p.598

2020

Volltextzugriff (PDF)

Predicting Biochemical Response to Clomiphene Citrate in Men with Hypogonadism

Journal of sexual medicine, 2014-09, Vol.11 (9), p.2302-2307

2014

Volltextzugriff (PDF)

Dovitinib: rationale, preclinical and early clinical data in urothelial carcinoma of the bladder

Expert opinion on investigational drugs, 2014-11, Vol.23 (11), p.1553-1562

2014

Volltextzugriff (PDF)

Impact of androgen deprivation therapy on sexual function

Asian journal of andrology, 2012-03, Vol.14 (2), p.198-203

2012

Volltextzugriff (PDF)

PD45-07 A COMPARISON OF ESTRADIOL LEVELS AND GYNECOMASTIA RATES IN HYPOGONADAL MEN USING CLOMIPHENE CITRATE VERSUS TRANSDERMAL TESTOSTERONE

The Journal of urology, 2015-04, Vol.193 (4), p.e904-e904

2015

Volltextzugriff (PDF)

MP83-13 COMPARATIVE MORBIDITY OF ABLATIVE ENERGY BASED SALVAGE TREATMENTS FOR RADIO-RECURRENT PROSTATE CANCER

The Journal of urology, 2015-04, Vol.193 (4), p.e1054-e1054

2015

Volltextzugriff (PDF)

MP78-08 LONG-TERM MORBIDITY AND ONCOLOGICAL OUTCOMES OF SALVAGE CRYOTHERAPY OF RADIO-RECURRENT PROSTATE CANCER

The Journal of urology, 2015-04, Vol.193 (4), p.e1005-e1005

2015

Volltextzugriff (PDF)

Androgen deprivation therapy before radical prostatectomy is associated with poorer postoperative erectile function outcomes

BJU international, 2012-07, Vol.110 (1), p.112-116

2012

Volltextzugriff (PDF)

Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?

BJU international, 2012-12, Vol.110 (11b), p.E570-E573

2012

Volltextzugriff (PDF)

Inhibition of endogenous hydrogen sulfide production in clear-cell renal cell carcinoma cell lines and xenografts restricts their growth, survival and angiogenic potential

Nitric oxide, 2015-09, Vol.49, p.26-39

2015

Volltextzugriff (PDF)

Exploring the Association Between Erectile Rigidity and Treatment Adherence With Sildenafil

Journal of sexual medicine, 2013-07, Vol.10 (7), p.1861-1866

2013

Volltextzugriff (PDF)

1398 ORGASM PROFILES IN MEN ON ANDROGEN DEPRIVATION THERAPY (ADT) FOR PROSTATE CANCER

The Journal of urology, 2013-04, Vol.189 (4), p.e572-e572

2013

Volltextzugriff (PDF)

1901 DEFINING THE UTILITY OF A CLINICAL CARE PATHWAY FOR CLOMIPHENE CITRATE USE IN MEN WITH HYPOGONADISM

The Journal of urology, 2013-04, Vol.189 (4), p.e779-e779

2013

Volltextzugriff (PDF)

1987 EX-VIVO TESTIS SPERM EXTRACTION IN MEN UNDERGOING ORCHIECTOMY FOR TESTIS CANCER

The Journal of urology, 2012-04, Vol.187 (4), p.e802-e802

2012

Volltextzugriff (PDF)

Three‐Year Outcomes of Recovery of Erectile Function after Open Radical Prostatectomy with Sural Nerve Grafting

Journal of sexual medicine, 2014-08, Vol.11 (8), p.2119-2124

2014

Volltextzugriff (PDF)

Penile Rehabilitation After Prostate Cancer Treatment: Outcomes and Practical Algorithm

Urologic clinics of North America, 2011-05, Vol.38 (2), p.105-118

2011

Volltextzugriff (PDF)

Pudendal schwannoma: A case report and literature review

Canadian Urological Association journal, 2014-03, Vol.8 (3-4), p.E199-E203

2014

Volltextzugriff (PDF)

1499 DEFINING THE RATE OF TACHYPHYLAXIS IN PATIENTS USING DAILY CLOMIPHENE CITRATE

The Journal of urology, 2012-04, Vol.187 (4), p.e607-e607

2012

Volltextzugriff (PDF)

MP35-15 DEVELOPING A PATIENT-DERIVED XENOGRAFT MODEL USING CHICKEN EMBRYOS TO PREDICT TARGETED THERAPY TUMOR RESISTANCE IN RENAL CELL CARCINOMAS

The Journal of urology, 2014-04, Vol.191 (4), p.e376-e376

2014

Volltextzugriff (PDF)

Abstract 5099: Abrogation of cancer cell extravasation in renal cell carcinoma PDX lines via invadopodia dysregulation mediated by PAK1 inhibitors

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.5099-5099

2015

Volltextzugriff (PDF)

MP74-16 ENUMERATION OF PROSTATE CANCER MICROPARTICLES AS A TOOL TO IDENTIFY PROSTATE CANCER

The Journal of urology, 2014-04, Vol.191 (4), p.e862-e862

2014

Volltextzugriff (PDF)

Abstract 3119: Predicting drug resistance in metastatic renal cell carcinoma: Personalized medicine by xenografting patient tumors into chicken embryos

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.3119-3119

2014

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Targeting the VEGF pathway in metastatic bladder cancer

Long-term Outcomes of Patients with Lymph Node Metastasis Treated with Radical Prostatectomy Without Adjuvant Androgen-deprivation Therapy

Animal models of spontaneous renal carcinoma: A possible rebirth?

Heading Towards a Possible Rebirth of the Induced Renal Cell Carcinoma Models?

Predicting Biochemical Response to Clomiphene Citrate in Men with Hypogonadism

Dovitinib: rationale, preclinical and early clinical data in urothelial carcinoma of the bladder

Impact of androgen deprivation therapy on sexual function

PD45-07 A COMPARISON OF ESTRADIOL LEVELS AND GYNECOMASTIA RATES IN HYPOGONADAL MEN USING CLOMIPHENE CITRATE VERSUS TRANSDERMAL TESTOSTERONE

MP83-13 COMPARATIVE MORBIDITY OF ABLATIVE ENERGY BASED SALVAGE TREATMENTS FOR RADIO-RECURRENT PROSTATE CANCER

MP78-08 LONG-TERM MORBIDITY AND ONCOLOGICAL OUTCOMES OF SALVAGE CRYOTHERAPY OF RADIO-RECURRENT PROSTATE CANCER

Androgen deprivation therapy before radical prostatectomy is associated with poorer postoperative erectile function outcomes

Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?

Inhibition of endogenous hydrogen sulfide production in clear-cell renal cell carcinoma cell lines and xenografts restricts their growth, survival and angiogenic potential

Exploring the Association Between Erectile Rigidity and Treatment Adherence With Sildenafil

1398 ORGASM PROFILES IN MEN ON ANDROGEN DEPRIVATION THERAPY (ADT) FOR PROSTATE CANCER

1901 DEFINING THE UTILITY OF A CLINICAL CARE PATHWAY FOR CLOMIPHENE CITRATE USE IN MEN WITH HYPOGONADISM

1987 EX-VIVO TESTIS SPERM EXTRACTION IN MEN UNDERGOING ORCHIECTOMY FOR TESTIS CANCER

Three‐Year Outcomes of Recovery of Erectile Function after Open Radical Prostatectomy with Sural Nerve Grafting

Penile Rehabilitation After Prostate Cancer Treatment: Outcomes and Practical Algorithm

Pudendal schwannoma: A case report and literature review

1499 DEFINING THE RATE OF TACHYPHYLAXIS IN PATIENTS USING DAILY CLOMIPHENE CITRATE

MP35-15 DEVELOPING A PATIENT-DERIVED XENOGRAFT MODEL USING CHICKEN EMBRYOS TO PREDICT TARGETED THERAPY TUMOR RESISTANCE IN RENAL CELL CARCINOMAS

Abstract 5099: Abrogation of cancer cell extravasation in renal cell carcinoma PDX lines via invadopodia dysregulation mediated by PAK1 inhibitors

MP74-16 ENUMERATION OF PROSTATE CANCER MICROPARTICLES AS A TOOL TO IDENTIFY PROSTATE CANCER

Abstract 3119: Predicting drug resistance in metastatic renal cell carcinoma: Personalized medicine by xenografting patient tumors into chicken embryos

Suchergebnisse filtern